Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

WHA announces progress of WHO Member States to conclude pandemic agreement

The agreement is aimed at preventing a repeat of the global health, economic and social impacts of the COVID-19 pandemic

- PMLiVE

The changemakers: authenticity is critical to successful transformation

Six observed behaviours of authentic change leaders

- PMLiVE

Creating a culture of inclusion

By Sarah Pollard and Claire Poynton

- PMLiVE

Revolutionising medical affairs with the power of omnichannel strategy

By Caroline Phillips

- PMLiVE

Pfizer’s one-time haemophilia B therapy Durveqtix receives CHMP recommendation

More than 38,000 people worldwide are currently affected by the inherited bleeding disorder

- PMLiVE

Moderna/Merck share positive three-year results for investigational skin cancer vaccine

More than 100,000 new cases of melanoma are expected to be diagnosed in the US in 2024

- PMLiVE

Takeda’s enzyme replacement therapy recommended by CHMP for rare blood clotting disorder cTTP

If approved, rADAMTS13 will be the first and only enzyme replacement therapy in the EU indicated for cTTP

- PMLiVE

Eli Lilly commits further $6.5m to UNICEF for young people at risk of noncommunicable diseases

The new funding builds on the company’s initial commitment of $14.4m in 2022

- PMLiVE

Driving diversity in clinical research

The positive impact of technology-enabled trials in ensuring equal representation for all

- PMLiVE

Purposeful communications: matchmaking patient and HCP influencers to deliver the impact you want

By Katy Davidson

- PMLiVE

Natural intelligence: healthcare comms in 2024

By Clare Middleton and Katie McMorran

- PMLiVE

De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a...

Petauri Evidence

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links